Viewing nowCombinationBonomax Plus D Tablet
Sodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.

MFDS item code 201405290 · Approved 2014.11.12 · Insurance code 644003540
Treatment of osteoporosis in postmenopausal women and men
Used for the treatment of osteoporosis in both postmenopausal women and men.
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. Discontinuation after 3~5 years of treatment should be considered in patients at low risk of fracture. Patients who discontinue treatment should be reassessed regularly for fracture risk. Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce the absorption of alendronate in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after your first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these directions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients whose dietary intake of calcium and vitamin D is inadequate should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. One weekly dose of this medicine provides one week's supply of vitamin D at daily amounts of 400 IU and 800 IU. If a patient taking 1 tablet of this medicine misses a dose on the scheduled day, take 1 tablet the next morning, resume the usual schedule on the originally scheduled day, and then continue regularly once weekly. Do not take 2 tablets on the same day. Administration to elderly patients (65 years and older): No dose adjustment is necessary. Administration to patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min), because there is insufficient clinical experience.
Children and adolescents (under 18 years): Safety and efficacy in children and adolescents have not been established.
This medication can irritate the upper gastrointestinal mucosa, causing esophageal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosion. If you experience difficulty swallowing, pain when swallowing, pain behind the sternum, or heartburn after taking the medication, stop taking it immediately and consult a doctor. Always take with a sufficient amount of water, and do not lie down for more than 30 minutes after taking it. Patients with esophageal motility disorders, those who cannot sit upright for at least 30 minutes, those who are hypersensitive to the ingredients, patients with hypocalcemia, or those with certain genetic metabolic disorders should not take this medication. In clinical trials, gastrointestinal symptoms such as abdominal pain, nausea, dyspepsia, constipation, and diarrhea were reported, as well as musculoskeletal pain and neurological symptoms such as headaches and dizziness. The risk of gastrointestinal adverse reactions may increase when taken with calcium supplements, antacids, aspirin, or non-steroidal anti-inflammatory drugs, so it should be taken at different intervals. During pregnancy, it should be administered cautiously considering the risk to the fetus, and nursing mothers should be careful as some ingredients can pass into breast milk. Not recommended for children or patients with severely impaired kidney function. Always take this medication in the morning before the first food, drink, or other medication with plenty of water, and do not chew or suck it. In rare cases, serious side effects such as atypical femoral fractures or osteonecrosis of the jaw may occur with long-term use, so regular check-ups and caution are necessary. In case of overdose, avoid inducing vomiting and maintain a stable posture with plenty of water; dialysis is not effective. Store this medication out of reach of children and do not transfer it to another container.
esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, dysphagia, odynophagia, retrosternal pain, heartburn, bleeding, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, taste disturbance, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, localized jawbone necrosis, joint swelling, low-energy fractures of the femoral head and other bones, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, choanal atresia
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. Also, keep it in a cool place between 1 and 30 degrees Celsius, avoiding direct sunlight.
White to grayish-white rectangular tablet
4 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Unimed Pharmaceutical Co., Ltd.
CombinationSodium Alendronate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
Sodium Alendronate Hydrate · Cholecalciferol Concentrate Powder
Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.